{
    "code": 0,
    "data": [
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call - Q3 FY26",
            "news_id": "32b7796d-f0af-4338-843a-ca0aca794931",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=735f829e-c6b6-4fea-ba4f-01770bcd3566.pdf",
            "news_date": "2026-02-10 18:00:25",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call - Q3 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=735f829e-c6b6-4fea-ba4f-01770bcd3566.pdf",
            "news_date": "2026-02-10 18:00:25"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) - Incident Of Fire At Our Manufacturing Plant Located At Hinjawadi Pune Maharashtra",
            "news_body": "Pursuant to Regulation 30 of the SEBI Listing Regulations this is to inform you that today i.e. February 07 2026 there was an incident of fire at the utility block at our manufacturing plant (Plant I) located at Hinjawadi Pune Maharashtra",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7250217b-a086-4767-b7fa-00c72362e065.pdf",
            "news_date": "2026-02-07 21:57:14"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4d2a46b-fcc5-4bef-a699-61097c75d691.pdf",
            "news_date": "2026-02-05 18:51:53"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call - Q3 FY26",
            "news_id": "c6462646-8287-494c-8bda-e46fae052447",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a546f43f-c112-4188-b852-4c7458bd922a.pdf",
            "news_date": "2026-02-04 18:35:15",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call - Q3 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a546f43f-c112-4188-b852-4c7458bd922a.pdf",
            "news_date": "2026-02-04 18:35:15"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015\r\n",
            "news_body": "Disclosure under Regulation 30(5) of the SEBI Listing Regulations intimating about authorising Key Managerial Personnel of the Company for the purpose of determining the materiality of an event and making disclosure to the Stock Exchanges.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19f96c15-10f9-49df-a301-e7e8e78ef88a.pdf",
            "news_date": "2026-02-04 15:07:11"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Re-appointment of Independent Directors of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba68c685-f4d8-4f1f-8131-27489de353dc.pdf",
            "news_date": "2026-02-04 14:29:29"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Appointment of Company Secretary / Compliance Officer",
            "caption": "Appointment of Company Secretary and Compliance Officer",
            "news_body": "Appointment of Ms. Amruta Jana Yangalwar as Company Secretary and Compliance Officer of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35011d8f-4378-4473-a4a6-464d4d7f8042.pdf",
            "news_date": "2026-02-04 14:08:09"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Consolidated And Standalone) For The Quarter And Nine Months Ended December 31 2025.",
            "news_body": "Unaudited Financial Results (Consolidated and Standalone) for the quarter and nine months ended December 31 2025",
            "news_id": "55cf2acf-2d17-41a6-a509-7eddfdd390c6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9b03194-f3ef-4604-827f-b9a8a963fd5d.pdf",
            "news_date": "2026-02-04 13:40:47",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results (Consolidated And Standalone) For The Quarter And Nine Months Ended December 31 2025.",
            "news_body": "Unaudited Financial Results (Consolidated and Standalone) for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9b03194-f3ef-4604-827f-b9a8a963fd5d.pdf",
            "news_date": "2026-02-04 13:40:47"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 04 2026.",
            "news_body": "Outcome of Board Meeting held on February 04 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb426b81-a204-484b-b18b-e5ce30a86c4f.pdf",
            "news_date": "2026-02-04 13:32:47"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation for Earnings Call - Q3 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=885354f5-5249-4bd7-905f-5dd77d55c005.pdf",
            "news_date": "2026-01-22 16:19:57"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2026 inter alia to consider and approve Board Meeting intimation for approval of Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0b332c8-4602-4fb5-abd0-200e96fab8a0.pdf",
            "news_date": "2026-01-22 16:05:14"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6d20053-497d-4c62-b7e7-94d33c259545.pdf",
            "news_date": "2026-01-07 13:24:48"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On US FDA Inspection At Our Manufacturing Facility Located At Kadu Surendranagar Gujarat India.",
            "news_body": "Intimation under Regulation 30 of SEBI Listing Regulations for Update on US FDA inspection at our manufacturing facility located at Kadu Surendranagar Gujarat India.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=859a1a16-9c19-4d4d-bee8-93eed04896a9.pdf",
            "news_date": "2025-12-23 18:11:12"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release titled \"Emcure expands Weight Management Therapy access with launch of Poviztra\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fda250f9-5bef-4905-a0a0-fb9e6042d6f0.pdf",
            "news_date": "2025-12-22 11:40:34"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of Equity Shares pursuant to exercise of ESOPs under the Emcure- Employee Stock Option Scheme 2013",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecebd231-f201-43ad-9e2b-44ec61b6cb53.pdf",
            "news_date": "2025-12-16 21:53:03"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of schedule of Analyst/ Investor Meeting(s)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95aaef64-584a-495c-b74b-1dda420e6128.pdf",
            "news_date": "2025-12-01 21:13:03"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Regarding Search And Seizure/ Inspection Operation Conducted By The Goods & Service Tax Department Mumbai Maharashtra.",
            "news_body": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 regarding search and seizure/ inspection operation conducted by Good & Service Tax Department Mumbai Maharashtra at offices of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42656134-9649-446c-8c6a-50b2600d75c9.pdf",
            "news_date": "2025-11-27 16:38:02"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Company Secretary / Compliance Officer",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer",
            "news_body": "Mr. Chetan Sharma (FCS:8352) has submitted his resignation from post of company Secretary and Compliance Officer & Key Managerial Personnel of the Company with effect from close of business hours on November 24 2025 to pursue opportunities outside the organization.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d47ff738-da7c-41ad-8ff8-53c443eed832.pdf",
            "news_date": "2025-11-21 17:57:10"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Investor Conferences to be attended by officials of the Company on November 19 2025 and November 20 2025",
            "news_id": "d4dddc56-2110-45cc-aa41-a59015c55eb9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d68fbde8-815b-4168-9eed-97c965b6ad1a.pdf",
            "news_date": "2025-11-19 11:07:49",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Investor Conferences to be attended by officials of the Company on November 19 2025 and November 20 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d68fbde8-815b-4168-9eed-97c965b6ad1a.pdf",
            "news_date": "2025-11-19 11:07:49"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Receipt Of No-Objection Letter For Reclassification Of Shareholding From Promoter And Promoter Group Category To Public Category In Accordance With Regulation 31A Of The Securities And Exchange Board Of India (Listing Obligations And Disclos",
            "news_body": "Intimation of receipt of No-objection Letter for reclassification of Shareholding from \"Promoter and Promoter Group\" category to \"Public\" category in accordance with Regulation 31A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73fd1907-cd5f-42df-869c-1ff8e9c7af9a.pdf",
            "news_date": "2025-11-18 14:56:14"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call - Q2 FY26",
            "news_id": "eaeb6386-0ce4-4515-9e7e-41383aa11a7e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=615067f0-f75b-4b11-918e-e8edfd924ae8.pdf",
            "news_date": "2025-11-17 16:36:50",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call - Q2 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=615067f0-f75b-4b11-918e-e8edfd924ae8.pdf",
            "news_date": "2025-11-17 16:36:50"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of schedule of Analyst/ Investor Meeting(s)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e896e279-bd50-4ca3-88d8-55e618b73826.pdf",
            "news_date": "2025-11-14 18:24:15"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of schedule of Analyst/ Investor Meeting(s)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4a3cfba-854b-413c-9631-647dc39ee25f.pdf",
            "news_date": "2025-11-14 18:21:29"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of Unaudited Financial Results of the Company for the quarter and half-year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d91cbc0-ce3e-4f71-ba21-450c00adba00.pdf",
            "news_date": "2025-11-13 16:19:03"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call - Q2 FY26",
            "news_id": "322cf092-07d6-46f2-bd76-f0a26846495a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11e0261d-7369-44fe-be09-84088a2c6bbf.pdf",
            "news_date": "2025-11-11 17:06:46",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call - Q2 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11e0261d-7369-44fe-be09-84088a2c6bbf.pdf",
            "news_date": "2025-11-11 17:06:46"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Unaudited Financial Results (Consolidated And Standalone) For The Quarter And Half-Year Ended September 30 2025",
            "news_body": "Unaudited Financial Results (Consolidated and Standalone) for the quarter and half-year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac4a1e8d-ab5f-48a5-a04b-68c395191965.pdf",
            "news_date": "2025-11-11 13:39:19"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half-Year Ended September 30 2025",
            "news_body": "Unaudited Financial Results (Consolidated and Standalone) for the quarter and half-year ended September 30 2025",
            "news_id": "87183aee-4332-454e-a410-2ae5d1cf717b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d0d8415-d775-41fe-aae8-92053a1ecac1.pdf",
            "news_date": "2025-11-11 13:35:29",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half-Year Ended September 30 2025",
            "news_body": "Unaudited Financial Results (Consolidated and Standalone) for the quarter and half-year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d0d8415-d775-41fe-aae8-92053a1ecac1.pdf",
            "news_date": "2025-11-11 13:35:29"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "A press release titled \"Novo Nordisk India partners with Emcure Pharma to commercialise Poviztra in India as a second brand of Wegovy.\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da1ce7dc-5ea4-474b-95d8-9db846eb61ea.pdf",
            "news_date": "2025-11-10 11:26:56"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation for Earnings Call - Q2 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9ae39c7-70a6-4dd8-bb8e-48dbd60ad4aa.pdf",
            "news_date": "2025-11-03 17:49:48"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half-Year Ended September 30 2025",
            "news_body": "Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve unaudited financial results (standalone and consolidated) for the quarter and half-year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d8416dbe-00ff-4c19-9db5-790fa0d1ec1d.pdf",
            "news_date": "2025-11-03 17:32:48"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Intimation under Regulation 30 of the SEBI Listing Regulations 2015 - Revision in Credit Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3781f96f-3d49-42dd-b2c2-fe979a8930ca.pdf",
            "news_date": "2025-10-17 18:48:14"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) - US FDA Inspection At Our Manufacturing Facility Located At Kadu Surendranagar Gujarat India.",
            "news_body": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (\"SEBI Listing Regulations\") - US FDA inspection at our manufacturing facility located at Kadu Surendranagar Gujarat India.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3724ff5-47b3-4b46-a802-7262b1c57df0.pdf",
            "news_date": "2025-10-10 13:42:40"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Revision in Credit Ratings",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6cc1b4a-10e4-4abb-87ea-72d0748ca439.pdf",
            "news_date": "2025-10-08 18:41:14"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Confirmation under Regulation 74(5) of the SEBI (Depositories and participants) Regulations 2018 for the quarter ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22dca139-96ff-43e0-b0ee-62e93e1ccb5c.pdf",
            "news_date": "2025-10-08 15:57:16"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Withdrawal Of Re-Classification Application Under Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Intimation of withdrawal of re-classification application under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=88435b5a-68d1-4ace-a457-bfd7b03fe94f.pdf",
            "news_date": "2025-10-07 18:53:14"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Change In Email Address Of MUFG Intime India Private Limited Registrar And Share Transfer Agent Of The Company.",
            "news_body": "Intimation of change in email address of MUFG Intime India Private Limited Registrar and Share Transfer Agent of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a8880a4-bd65-480a-b8e6-eb4f6238dc28.pdf",
            "news_date": "2025-10-06 18:17:55"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Intimation under Regulation 30 of the SEBI (LODR) Regulation 2015 - Update on completion of acquisition of shares of Zuventus Healthcare Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3efa026-4802-4b8e-8800-395516222738.pdf",
            "news_date": "2025-10-03 19:01:28"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Intimation under Regulation 30 of SEBI Listing Regulations 2015 for allotment of Equity Shares pursuant to exercise of ESOPs under the Emcure - Employee stock Options Scheme 2013",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0908d60-f51a-474e-af46-58341e729be6.pdf",
            "news_date": "2025-09-29 19:46:51"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e176714f-2cb9-4d13-aede-34da48dde747.pdf",
            "news_date": "2025-09-26 16:46:01"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On Re-Appointment Of Dr. Mukund Gurjar As A Whole-Time Director And Appointment Of Secretarial Auditor Of The Company.",
            "news_body": "Update on Re-appointment of Dr. Mukund Gurjar as a Whole-time Director and Appointment of Secretarial Auditor of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9525f15-0763-40b0-8564-8eabb04f8e3d.pdf",
            "news_date": "2025-08-29 20:28:41"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Voting Results of the 44th Annual General Meeting of the Company along-with consolidated Report of the Scrutinizer.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26c85904-fb87-4357-96b2-81fbe8e8ce55.pdf",
            "news_date": "2025-08-29 20:19:59"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Proceedings of the 44th Annual General Meeting of the Members of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eed443f5-294f-45a9-88c4-77fe7506b39c.pdf",
            "news_date": "2025-08-28 17:50:28"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call - Q1 FY26 held on August 07 2025 at 3.30 pm (IST)",
            "news_id": "9b70a444-cb7c-4a63-a7bb-dbac6fc13a05",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4ed26ca-76ef-422a-a01e-753ea63ac0ac.pdf",
            "news_date": "2025-08-13 15:56:17",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call - Q1 FY26 held on August 07 2025 at 3.30 pm (IST)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4ed26ca-76ef-422a-a01e-753ea63ac0ac.pdf",
            "news_date": "2025-08-13 15:56:17"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of Unaudited Financial Results of the Company for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c70b5c11-15c5-4242-a707-0509a7be345d.pdf",
            "news_date": "2025-08-08 15:23:26"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 And 36(1)(B) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 About Dispatch Of Letters To The Members Whose E-Mail Addresses Are Not Registered With The Company/ Depository Participants.",
            "news_body": "Intimation under Regulation 30 and 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 about dispatch of letters to the Members whose e-mail addresses are not registered with the Company/ Depository Participants.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f435a7b6-72a0-4241-9c0b-acfacf20b58f.pdf",
            "news_date": "2025-08-07 21:50:14"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call - Q1 FY26",
            "news_id": "5de69580-b23b-4f3b-b65f-abf969c0af48",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=241e7714-1290-4057-aa22-7a33144873d2.pdf",
            "news_date": "2025-08-07 21:31:25",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call - Q1 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=241e7714-1290-4057-aa22-7a33144873d2.pdf",
            "news_date": "2025-08-07 21:31:25"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On August 07 2025 To Approve The Unaudited Financial Results (Consolidated And Standalone) For The Quarter Ended June 30 2025",
            "news_body": "Outcome of the Board Meeting held on August 07 2025 to approve the Unaudited Financial Results (Consolidated and Standalone) for the quarter ended June 30 2025",
            "news_id": "4e9a8815-f5e8-48dc-8e89-2e1805faa4e2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a1385be-7335-4286-b3ed-f75dcf89f7e2.pdf",
            "news_date": "2025-08-07 13:42:10",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On August 07 2025 To Approve The Unaudited Financial Results (Consolidated And Standalone) For The Quarter Ended June 30 2025",
            "news_body": "Outcome of the Board Meeting held on August 07 2025 to approve the Unaudited Financial Results (Consolidated and Standalone) for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a1385be-7335-4286-b3ed-f75dcf89f7e2.pdf",
            "news_date": "2025-08-07 13:42:10"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On August 07 2025",
            "news_body": "Outcome of Board Meeting held on August 07 2025 to approve the Unaudited Financial Results (Consolidated and Standalone) for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e30099d-4d02-47f8-98db-b61830613dcb.pdf",
            "news_date": "2025-08-07 13:33:08"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Newspaper Advertisement of Notice of the 44th Annual General Meeting and e-voting information.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d2f5f49-f27d-469d-aab0-27a083b6fa5d.pdf",
            "news_date": "2025-08-03 12:59:18"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Intimation Of Notice Of The 44Th Annual General Meeting Of Emcure Pharmaceuticals Limited To Be Held On Thursday August 28 2025",
            "news_body": "Intimation of Notice of the 44th Annual General Meeting of Emcure Pharmaceuticals Limited to be held on Thursday August 28 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c256c54-d4d5-4f33-8fb4-7eecf52f3566.pdf",
            "news_date": "2025-08-02 17:05:09"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report for the Financial Year 2024-25 and the Notice of the 44th Annual General Meeting of Emcure Pharmaceuticals Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fa3f6b5-6c40-45ed-8a66-ad9c4336d473.pdf",
            "news_date": "2025-08-02 16:49:40"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of The 44Th AGM And Record Date For Final Dividend For The Financial Year Ended March 31 2025.",
            "news_body": "Intimation of the 44th AGM and Record date for Final Dividend for the financial year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61915584-bdeb-4fe0-8bd8-02022531d7b6.pdf",
            "news_date": "2025-08-01 18:58:13"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation for Earnings Call - Q1 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0876d74-0b0c-42af-ab37-fc1fd37445dd.pdf",
            "news_date": "2025-07-28 17:56:55"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025.",
            "news_body": "Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 inter alia to consider and approve unaudited financial results (standalone and consolidated) for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a7135f8-cc2f-4b21-b105-1ac57a6a8b04.pdf",
            "news_date": "2025-07-28 17:47:18"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release titled - \"Emcure Pharmaceuticals Ltd. and Sanofi India Limited Announce Exclusive Distribution Partnership to Broaden Reach of Sanofis Oral Anti-diabetic Drugs\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=125a7f7c-9e50-417b-bafd-9341e24bffeb.pdf",
            "news_date": "2025-07-16 17:20:04"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Intimation under Regulation 30 of the SEBI (LODR) Regulations 2015 - Appointment of Mr. R.S. Vasan as President - India Business and Senior Management Personnel of the Company w.e.f. July 14 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=194b34e0-7a1e-432b-9637-30eecb8315fa.pdf",
            "news_date": "2025-07-14 13:12:39"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) - US FDA Inspection At Our Manufacturing Facility (Oncology) Located At Sanand Ahmedabad Gujarat India.",
            "news_body": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - US FDA inspection at our manufacturing facility (Oncology) located at Sanand Ahmedabad Gujarat India",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=688c731d-3f6c-4530-bf78-a148b5336198.pdf",
            "news_date": "2025-07-09 17:22:13"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86e986a5-9647-4d06-8c9e-4e9d190e0df8.pdf",
            "news_date": "2025-07-09 16:09:46"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Incorporation of a Wholly-owned Subsidiary of the Company with the name \"Emcure Wellness Private Limited\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53581288-aa1a-4f20-aed7-d971174986df.pdf",
            "news_date": "2025-07-04 14:51:19"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d08be3ad-a401-4f89-a098-e9a85bcbc0be.pdf",
            "news_date": "2025-06-25 19:53:40"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Submission Of Application For Seeking Re-Classification From The Promoter And Promoter Group Category To Public Category",
            "news_body": "Intimation under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015- Submission of application for seeking re-classification from the \" Promoter and Promoter Group category to Public category",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f31bac9-6425-4380-a136-75186c919d26.pdf",
            "news_date": "2025-06-25 19:47:12"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Award of Order / Receipt of Order",
            "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby submit the disclosure regarding an Order received from the Office of the Regional Director Western Region Ministry of Corporate Affairs Mumbai on June 24 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c65addd0-d6a8-4b2f-8d34-dafe0fecf514.pdf",
            "news_date": "2025-06-25 17:55:15"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Of Key Performance Indicators (Kpis) Under The SEBI (Issue Of Capital And Disclosure Requirements) Regulations 2018",
            "news_body": "Disclosure of Key Performance Indicators (KPIs) under the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5965caee-6b21-4b66-a269-066c82650351.pdf",
            "news_date": "2025-06-21 14:08:43"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release (Revised)",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)",
            "news_body": "Please find enclosed herewith a Press Release titled \"Emcure Pharmaceuticals to Acquire Remaining Stake in its Subsidiary Zuventus Healthcare Ltd.\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f42b16e-e3a5-43df-ae66-a1be2f94ad79.pdf",
            "news_date": "2025-06-21 14:01:19"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Outcome Of The Meeting Of The Board Of Directors Considering Requests For Re-Classification From The Promoter And Promoter Group Category To P",
            "news_body": "Intimation under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Outcome of the meeting of the Board of Directors considering requests for re-classification from the \"Promoter and Promoter Group category to Public category",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef9b29f0-3174-4f60-8f26-0f27b625fab9.pdf",
            "news_date": "2025-06-21 13:56:16"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Intimation of proposed incorporation of a Wholly-owned subsidiary by the name \"Emcure Wellness Private Limited\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d908e90-a12d-4dad-bcb9-f8794d50eee8.pdf",
            "news_date": "2025-06-21 12:28:31"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Acquisition of Equity Shares constituting 20.42% of the total issued and paid-up capital of Zuventus Healthcare Limited a subsidiary of the Company thereby making Zuventus a wholly-owned subsidiary of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf1e925e-cb18-4a4f-b05b-f3c16c58f4a7.pdf",
            "news_date": "2025-06-21 12:02:28"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Outcome",
            "descriptor": "Outcome without intimation",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On June 21 2025",
            "news_body": "Outcome of Board Meeting held on June 21 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b55b067-1df9-4a2b-966d-58810e5733f9.pdf",
            "news_date": "2025-06-21 11:51:40"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Outcome Of Board Meeting Held On June 21 2025",
            "news_body": "Outcome of Board Meeting held on June 21 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe61d0d8-ff00-4ce6-a089-9ae1ff5b36e6.pdf",
            "news_date": "2025-06-21 11:49:59"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Receipt Of Requests For Re-Classification From The Promoter And Promoter Group Category To Public Category",
            "news_body": "Intimation under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Receipt of requests from members of the Promoter and Promoter Group of the Company seeking re-classification from the Promoter and Promoter Group category to Public category.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1cce52b9-61e9-4ecf-8546-52bb9c261d6c.pdf",
            "news_date": "2025-06-19 17:44:37"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of schedule of Analyst/ Investor Meeting(s) to be held on Monday June 23 2025  & Tuesday June 24 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab082a5b-626e-4ce4-b665-ef24409a7420.pdf",
            "news_date": "2025-06-18 20:32:28"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of schedule of Analyst/ Investor Meeting(s) to be held on Monday June 23 2025  & Tuesday June 24 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3096128-91da-4e80-bfab-9b47ba48c722.pdf",
            "news_date": "2025-06-18 20:27:47"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Incorporation of a Wholly-owned Subsidiary of the Company with name \"Emcure Lifesciences Private Limited\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0aa04850-f6c8-40f4-a041-559922c91b32.pdf",
            "news_date": "2025-06-17 19:34:10"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Intimation under Regulation 30 of SEBI Listing Regulations 2015 for allotment of Equity Shares pursuant to exercise of ESOPs under the Emcure - Employee Stock Option Scheme 2013",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a0161ee-a9a0-427e-8b60-585378b11373.pdf",
            "news_date": "2025-06-12 19:03:04"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Resignation of Senior Management Personnel of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37bbfd1f-6095-43c8-9f90-40b604073a33.pdf",
            "news_date": "2025-06-03 19:23:31"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (\"Listing Regulations\") we would like to inform that Emcure Pharmaceuticals Limited (\"Emcure\") has entered into a Share Subscription and Shareholders Agreement and Power Transfer Agreement(s) dated June 02 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75441aa8-bb0a-4adc-81f1-7345472e02c7.pdf",
            "news_date": "2025-06-02 20:21:14"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The transcript of Earnings Call for Q4 FY 25 held on May 22 2025 at 3:30 P.M. (IST)",
            "news_id": "1bcd9694-5993-41ef-8c77-d5cce851f6a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b44febc-6ee7-4bd6-88cb-46a4faedbb39.pdf",
            "news_date": "2025-05-28 18:12:02",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The transcript of Earnings Call for Q4 FY 25 held on May 22 2025 at 3:30 P.M. (IST)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b44febc-6ee7-4bd6-88cb-46a4faedbb39.pdf",
            "news_date": "2025-05-28 18:12:02"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Disclosure under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Annual Secretarial Compliance Report for the Financial Year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31ce3c05-5a6a-4390-9073-ac44bd41ecb5.pdf",
            "news_date": "2025-05-27 18:43:38"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Clarification On Volume Movement Letter",
            "news_body": "Clarification on Volume Movement Letter",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ba4ed9d-6fa9-4f9b-b7ae-d1d35a51ed18.pdf",
            "news_date": "2025-05-27 13:56:05"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Emcure Pharmaceuticals Ltd",
            "news_body": "The Exchange has sought clarification from Emcure Pharmaceuticals Ltd on May 27 2025 with reference to Movement in Volume. <BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-05-27 12:57:49"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of Audited Financial Results of the Company for the quarter and year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f565b3b-2f73-4fc3-b9dc-5de3ceb7044e.pdf",
            "news_date": "2025-05-23 15:38:52"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call - Q4 FY25",
            "news_id": "d5cc0d50-81b5-4a98-a3d7-834ada151ba1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f17d4c1a-498c-4030-8ca8-09a9505b8448.pdf",
            "news_date": "2025-05-22 18:24:14",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Call - Q4 FY25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f17d4c1a-498c-4030-8ca8-09a9505b8448.pdf",
            "news_date": "2025-05-22 18:24:14"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Code of Conduct under SEBI (PIT) Regulations 2015",
            "caption": "Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015",
            "news_body": "Disclosure under Regulation 8(2) of SEBI (Prohibition of Insider Trading) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcde4b82-2e7e-4054-a3d8-7a492da7992d.pdf",
            "news_date": "2025-05-22 16:13:28"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Intimation of proposed incorporation of a Wholly-owned Subsidiary by the name \"Emcure Generics Private Limited\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67d005e3-0ef6-465b-a81c-9257000f5449.pdf",
            "news_date": "2025-05-22 15:50:08"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Appointment Of Secretarial Auditor",
            "news_body": "Appointment of M/s. SVD & Associates Company Secretaries in Practice as the Secretarial Auditors of the Company for a term of 5 (five) consecutive years commencing from financial year 2025-26 subject to approval by the Members at the ensuing Annual General Meeting  of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8001ee99-8587-4a56-9e8d-9a48677a75ef.pdf",
            "news_date": "2025-05-22 15:27:49"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Re-appointment of Dr. Mukund Gurjar as a Whole-time Director of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1dabbc7f-edc5-43ed-969c-8128f5d1fecf.pdf",
            "news_date": "2025-05-22 15:10:40"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31 2025",
            "news_body": "Audited Financial Results for the quarter and year ended March 31 2025",
            "news_id": "d2a3b41c-5baa-48ff-a2be-f6d2ddd7c5ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=309bfcf3-0319-4369-8c8e-8e5cd874ed98.pdf",
            "news_date": "2025-05-22 14:49:20",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31 2025",
            "news_body": "Audited Financial Results for the quarter and year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=309bfcf3-0319-4369-8c8e-8e5cd874ed98.pdf",
            "news_date": "2025-05-22 14:49:20"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Recommendation of Final Dividend for the financial year 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7c76521-3ceb-48b6-a57b-0430e87b4da8.pdf",
            "news_date": "2025-05-22 14:37:18"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On May 22 2025",
            "news_body": "Outcome of Board Meeting held on May 22 2025:\r\n1. Audited Financial Results (standalone and consolidated) for the quarter and year  ended March 31 2025.\r\n2. Dividend\r\n3. Re-appointment of Dr. Mukund Gurjar (DIN: 00026843) as a Whole-time Director of the Company\r\n4. Appointment of Secretarial Auditors of the Company\r\n5. Incorporation of a wholly-owned Subsidiary by the name Emcure Generics Private Limited in Pune Maharashtra India",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f40139e-de65-464c-9211-ccc8daddd305.pdf",
            "news_date": "2025-05-22 14:28:14"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended we wish to inform  that the Earnings Call for Investors/ Analysts will be held on Thursday May 22 2025 at 3:30 p.m. (IST) to discuss the Audited Financial Results (standalone and consolidated) and performance for the quarter and year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2934f797-1583-4978-b746-5a02e65f9776.pdf",
            "news_date": "2025-05-13 20:11:25"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31 2025",
            "news_body": "Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 inter alia to consider and approve Audited financial results (standalone and consolidated) for the quarter and year ended March 31 2025 and recommendation of Final Dividend if any.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a634a1ed-8c43-43e1-b941-82e7c899df33.pdf",
            "news_date": "2025-05-13 19:37:39"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) - Update On USFDA Inspection At API Manufacturing Facility Located At Kurkumbh Pune Maharashtra India",
            "news_body": "Announcement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (\"SEBI Listing Regulations\") - Update on USFDA inspection at API manufacturing facility located at Kurkumbh Pune Maharashtra India",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08a14379-a109-43f5-92aa-c43577341bc2.pdf",
            "news_date": "2025-04-18 17:09:54"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Change In Email And Website Address Of Registrar And Share Transfer Agent Of The Company",
            "news_body": "Intimation of change in email and website address of Registrar and Share Transfer Agent of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37ab3504-a6c6-40b8-94cc-579c9d63318a.pdf",
            "news_date": "2025-04-18 16:57:27"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Confirmation Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2025 received from MUFG Intime India Private Limited the Registrar and Share Transfer Agent (RTA) of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76cb43fb-2000-483e-8a3b-95a16cc45399.pdf",
            "news_date": "2025-04-08 16:25:47"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please find enclosed herewith a Press Release titled \"Emcures European subsidiary Tillomed acquires strategic pharma portfolio from Manx.\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2d1ffaf-be3f-452d-a3bb-087973e2f01b.pdf",
            "news_date": "2025-04-04 12:15:39"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please find enclosed herewith a Press Release titled \"Emcutix and WiQo Signs Exclusive Licensing Partnership to revolutionize Derma-cosmetic Treatments in India\" by Emcutix Biopharmaceuticals Limited a subsidiary of Emcure Pharmaceuticals Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2deb745-6473-4375-bd9c-25eb2379b216.pdf",
            "news_date": "2025-04-01 12:51:49"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please find enclosed herewith a Press Release titled \"Gennova Advances Pathbreaking AI-Enhanced saRNA Vaccine for one of the deadliest known viruses in collaboration with CEPI\" by Gennova Biopharmaceuticals Limited a subsidiary of Emcure Pharmaceuticals Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a12f1a10-6e68-49f4-9538-63f41894ada3.pdf",
            "news_date": "2025-03-31 18:15:19"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9633688e-d623-4646-86ee-f78ca61e90bf.pdf",
            "news_date": "2025-03-25 18:20:59"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Intimation under Regulation 30 of SEBI Listing Regulations 2015 for allotment of Equity Shares pursuant to exercise of ESOPs under the Emcure- Employee Stock Option Scheme 2013",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26a43045-29c0-46cd-b2d6-59d487da82d3.pdf",
            "news_date": "2025-03-24 19:49:25"
        },
        {
            "co_code": 16966,
            "bse_code": 544210,
            "isin": "INE168P01015",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release titled \"Emcure Expands OTC Portfolio with Arth Supplements Welcomes Vidya Balan as Brand Ambassador\".",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd04f51e-8c3a-41c3-aa9e-446753437107.pdf",
            "news_date": "2025-03-10 16:34:41"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The transcript of the Earnings Call for the Q3 FY25 held on February 06 2025 at 5:30 p.m. (IST)",
            "news_id": "1a9458a0-325f-4cd4-a4e0-46070ebbfd3c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e7ff1a5-c6ae-490a-a58a-d9d512129ebd.pdf",
            "news_date": "2025-02-11 18:36:16",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Consolidated And Standalone) For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Unaudited Financial Results (Consolidated & Standalone) For the quarter and nine months ended December 31 2024",
            "news_id": "d6a5055e-3308-4dc4-b1da-a7e11ca0a368",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d46a6a1e-f799-45eb-bb40-a9679165f9d8.pdf",
            "news_date": "2025-02-06 15:04:10",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated October 29, 2024, please find enclosed the transcript of the Earnings Call for the Q2 FY25, held on Thursday, November 07, 2024, at 6.30 p.m. (IST).",
            "news_id": "0d0177d9-1f3b-4465-830a-415c1c8567ca",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6265d94f-e2f0-44d4-a79e-83887697f462.pdf",
            "news_date": "2024-11-13 17:22:07",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated October 29, 2024 regarding earnings call, the audio recording of the call held yesterday i.e. on November 07, 2024, is available on our website. The said audio recording can be accessed through the below web address:https://www.emcure.com/wp-content/uploads/2024/11/EMC0220241107156104.mp3",
            "news_id": "7a2dceca-4b75-44aa-9acf-5f9aa16b9245",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14d4f1d4-b3e2-4e0a-8f9c-2945675bf3f6.pdf",
            "news_date": "2024-11-08 17:38:06",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Outcome of Board Meeting held on November 7, 2024",
            "news_id": "b5def008-639e-40bd-9d8e-3c1430716b31",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=022ed7d1-8856-41da-be40-18822b7dcd79.pdf",
            "news_date": "2024-11-07 15:41:31",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform that the Earnings Call for Investors/ Analysts will be held on Thursday, November 07, 2024 at 6:30 p.m. (IST) to discuss the Company''s unaudited financial results (standalone and consolidated) and performance for the quarter ended September 30, 2024.The details of the aforesaid earnings call for Investors/Analysts is enclosed.The transcript and the audio recording of the Earnings Call will be made available on the Company's website and will be intimated accordingly.",
            "news_id": "ce41d401-b363-4751-8948-21a176dd90eb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2cebbdd-4a59-40ba-9a7c-5fac707f1f34.pdf",
            "news_date": "2024-10-29 19:03:04",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and further to our intimation dated August 8, 2024, please find enclosed the transcript of the Earnings Call for the Q1 FY25, held on Wednesday, August 14, 2024 at 8.30 a.m. (IST).",
            "news_id": "5855083c-b694-4d66-94f1-2f0719626a3f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=359c6789-0a69-4e2d-a8fb-5bd840334030.pdf",
            "news_date": "2024-08-19 16:52:13",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated August 8, 2024, regarding earnings call, the audio recording of the call held today is available on our website.",
            "news_id": "93527dd9-d0b7-4e93-81d1-d36620d1d714",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c481e23-913f-4cf7-a784-2b599197141e.pdf",
            "news_date": "2024-08-14 17:06:20",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "EMCURE",
            "disp": "Emcure Pharmaceuticals",
            "bse_code": 544210,
            "isin": "INE168P01015",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On August 13, 2024",
            "news_body": "Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Unaudited Financial Results for the quarter ended June 30, 2024, along with the Limited Review Reports on the aforesaid results as issued by the B S R & Co. LLP, Chartered Accountants, Auditors of the Company, enclosed as Annexure A.Press Release outlining key updates on the aforesaid results are enclosed as Annexure B.",
            "news_id": "634b5690-b948-4723-b6c0-09ae5f2cab58",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5fffcca-b928-42b4-82d0-64a9a7dc519f.pdf",
            "news_date": "2024-08-13 21:13:50",
            "seo": "emcure-pharmaceuticals-ltd",
            "ltp": 1498.8,
            "ch": -11.5,
            "pch": -0.7614381248758525,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 24398,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}